Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 23, 2014 07:30 ET | Source: Lisata Therapeutics

NeoStem Set to Join Multiple Russell Indexes

NEW YORK, June 23, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS), a leader in the emerging cellular therapy industry, announced today that it is set to join the broad-market Russell Global,...
June 16, 2014 07:30 ET | Source: Lisata Therapeutics

NeoStem Announces UCSF Presentation of Phase 1 Results for T Regulatory Cell Immunotherapy for Type 1 Diabetes at American Diabetes Association Annual Meeting

-- Preliminary Data Indicate Safety and Tolerability in Adult Patients and Complement Recently Published 12-Month Data Indicating Feasibility and Potential Efficacy in Children With T1DM -- --...
June 12, 2014 19:15 ET | Source: Lisata Therapeutics

NeoStem Clarification: No New Securities Being Issued

NEW YORK, June 12, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS), a leader in the emerging cellular therapy industry, is issuing this press release to clarify for shareholders that NeoStem is...
June 03, 2014 07:30 ET | Source: Lisata Therapeutics

NeoStem Announces Access to New $30 Million Equity Facility With Aspire Capital to Replace the Fully Drawn Facility

NEW YORK, June 3, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, today announced that it has filed today with the...
May 29, 2014 07:30 ET | Source: Lisata Therapeutics

NeoStem Presents Five-Year Survival Data for Autologous Melanoma Immunotherapy Targeting Cancer Stem Cells at American Society of Clinical Oncology Annual Meeting

-- Pooled Analysis of Early-Phase Studies Indicates Melapuldencel-T, an Investigational Immunotherapy for Metastatic Melanoma Targeting Cancer Initiating (Stem) Cells, May Increase Survival Rates...
May 28, 2014 07:30 ET | Source: Lisata Therapeutics

NeoStem to Present at Multiple June Conferences

NEW YORK, May 28, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, announced today that the Company will present at...
May 27, 2014 07:30 ET | Source: Lisata Therapeutics

NeoStem Announces Grant of Two U.S. Patents for CD34 Cell Program

NEW YORK, May 27, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, today announced the expansion of intellectual...
May 21, 2014 07:30 ET | Source: Lisata Therapeutics

NeoStem Announces CEO Dr. Robin L. Smith Selected as Finalist for EY Entrepreneur of the Year 2014 Award

NEW YORK, May 21, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, announced today that Dr. Robin L. Smith,...
May 19, 2014 07:30 ET | Source: Lisata Therapeutics

NeoStem Expands Patent Portfolio With Grant of Two European Patents

NEW YORK, May 19, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, today announced the expansion of its...
May 15, 2014 07:30 ET | Source: Lisata Therapeutics

NeoStem's Subsidiary, Progenitor Cell Therapy (PCT), Awarded FACT Re-Accreditation for New Jersey and California Facilities

NEW YORK, May 15, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, and its subsidiary, Progenitor Cell Therapy, LLC...